News | January 10, 2023
Vidita Vaidya awarded Infosys Prize 2022 in Life Sciences
In a time when conversations around mental health have become ever more urgent Vaidya’s work is extremely contextual
In a time when conversations around mental health have become ever more urgent Vaidya’s work is extremely contextual
The new facility will be able to handle four times as many patients as the previous facility.
The group now has 322 approvals and has so far filed over 428 ANDAs since the commencement of the filing process in FY 2003-04
Abbott has recently received the US Food and Drug Administration nod to use its DBS device for treatment-resistant depression
A newly revealed mechanism by Weizmann Institute of Science of ketamine’s action on potassium channels in neurons may lead to improved therapies for depression
'Hello Skin' has been developed in collaboration with the IADVL (Indian Association of Dermatologists, Venereologists and Leprologists)
Dupixent is the first and only medicine indicated to treat eosinophilic esophagitis in the United States; approval granted more than two months ahead of USFDA’s Priority Review action date
The icare4u program features a dedicated website, with comprehensive information about the diseases, videos with medical experts, and a social media community for patients and caregivers on Facebook and YouTube
CB03 is a candidate drug for the treatment of refractory epilepsy, independently developed by Zhimeng
The companies expect to complete the submission of the NDA for treatment of MDD in the second half of 2022; associated filing for postpartum depression is anticipated in the first half of 2023
Subscribe To Our Newsletter & Stay Updated
